Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
China NMPA approves RareStone's pitolisant (Wakix) for the treatment of narcolepsy 2023-07-04 20:42
Skyline Therapeutics Receives FDA Clearance of IND for SKG0106, a Novel Intravitreally Delivered AAV Gene Therapy Candidate for Neovascular Age-related Macular Degeneration 2023-07-03 19:00
Henlius Forecasts Profit in 1H 2023 2023-07-03 17:49
Zymedi announced their collaboration with the National Heart, Lung, and Blood Institute through a CTA CRADA to develop ZMA001 mAb, a potential treatment for Pulmonary Arterial Hypertension (PAH), a rare, female predominant disease 2023-07-03 08:00
HaemaLogiX Announces Positive Final Results from KappaMab Combination Phase IIb Myeloma Trial 2023-06-29 19:00
Clarity establishes a US Center of Excellence for Targeted Copper Theranostics 2023-06-28 20:58
Sanyou Forms Partnership with Hangzhou Zhongmei Huadong Pharmaceutical, Catalyzing Innovative Drug Research and Development 2023-06-28 20:00
LYMPHOMA THERAPY NOW APPROVED FOR AUSTRALIAN PATIENTS With Diffuse Large B-cell Lymphoma 2023-06-28 04:00
HitGen launches a newly upgraded version of OpenDEL™, a self-service screening kit, to facilitate innovative drug discovery research 2023-06-26 21:30
SK pharmteco doubles viral vector production capacity in Europe 2023-06-23 07:30
BioCity Announces Initiation of a Phase 2 Trial for SC0062, a Promising ETA Receptor Antagonist for Chronic Kidney Disease 2023-06-22 08:02
Dr. Yinfei Yin Joins Shanghai ChemPartner as Vice President and Head of Biology and Pharmacology 2023-06-21 23:07
Nuvilab Awarded as 2023 Technology Pioneer by World Economic Forum 2023-06-21 15:30
bioSeedin attended 2023 BIO international convention for international licensing and partnership 2023-06-21 11:44
Jadeite Medicines Receives Orphan Drug Designation for Odevixibat in Progressive Familial Intrahepatic Cholestasis (PFIC) from the Ministry of Health, Labour and Welfare of Japan and will also initiate Phase 3 Trial of Odevixibat in PFIC in Japan 2023-06-21 09:00
Clarity commences COMBAT theranostic prostate cancer trial in the US 2023-06-20 21:03
Longbio Pharma Presented Positive Topline Phase 1 Results for LP-003 at ERS2023 2023-06-20 21:00
Curocell announced encouraging updates on the next-generation anti-CD19 CAR-T, Anbalcabtagene-autoleucel at International Conference on Malignant Lymphoma (ICML) 2023 2023-06-20 08:01
The U.S. FDA Approved the Phase I/II Clinical Trial Application to Evaluate LBL-033, An Anti-MUC16/CD3 Bispecific Antibody Developed by Leads Biolabs, in Advanced Solid Tumors Including Ovarian Cancer 2023-06-16 22:01
SeekIn paves the way for cancer early detection in low- and middle-income countries 2023-06-16 21:00
1 48 49 50 51 52 223